Renamed to ALBT in Jan 2023
AVCO - Avalon GloboCare Corp.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Freehold,
United States
Type: Equity
AVCO price evolution
AVCO
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.18 | $0.53 | $0.81 | $0.53 |
| Short term investments | ||||
| Net receivables | $0.23 | $0.25 | $0.23 | $0.23 |
| Inventory | ||||
| Total current assets | $1.65 | $0.91 | $1.32 | $1.26 |
| Long term investments | $0.52 | $0.5 | $0.52 | $0.52 |
| Property, plant & equipment | $7.78 | $7.92 | $8.04 | $8.15 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $8.62 | $8.76 | $8.92 | $9.14 |
| Total investments | $0.52 | $0.5 | $0.52 | $0.52 |
| Total assets | $10.28 | $9.67 | $10.24 | $10.39 |
| Current liabilities | ||||
| Accounts payable | $0.38 | $0.06 | $0.05 | |
| Deferred revenue | ||||
| Short long term debt | $0.57 | $0.12 | $0.54 | $0.54 |
| Total current liabilities | $7.21 | $5.15 | $4.4 | $4.54 |
| Long term debt | $2.44 | $3.24 | $2.76 | $4 |
| Total noncurrent liabilities | $2.89 | $3.24 | $2.76 | $4 |
| Total debt | $3.01 | $3.36 | $3.3 | $4.54 |
| Total liabilities | $10.1 | $8.39 | $7.16 | $8.54 |
| Shareholders' equity | ||||
| Retained earnings | -$55.23 | -$53.2 | -$51.13 | -$48.8 |
| Other shareholder equity | -$0.21 | -$0.16 | -$0.17 | -$0.18 |
| Total shareholder equity | $0.17 | $1.28 | $3.08 | $1.85 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.81 | $0.73 | $0.76 | $2.25 |
| Short term investments | ||||
| Net receivables | $0.23 | $0.15 | $0.34 | $0.05 |
| Inventory | $0.01 | |||
| Total current assets | $1.32 | $1.29 | $1.57 | $3.63 |
| Long term investments | $0.52 | $0.52 | $0.48 | $0.39 |
| Property, plant & equipment | $8.04 | $8.3 | $8.34 | $8.13 |
| Goodwill & intangible assets | $1.26 | |||
| Total noncurrent assets | $8.92 | $9.08 | $8.92 | $9.77 |
| Total investments | $0.52 | $0.52 | $0.48 | $0.39 |
| Total assets | $10.24 | $10.37 | $10.49 | $13.4 |
| Current liabilities | ||||
| Accounts payable | $0.09 | $0.08 | $0.11 | |
| Deferred revenue | $0.03 | |||
| Short long term debt | $0.54 | $0.08 | ||
| Total current liabilities | $4.4 | $2.59 | $2.84 | $1.14 |
| Long term debt | $2.76 | $3.66 | $3.19 | $1 |
| Total noncurrent liabilities | $2.76 | $3.66 | $3.19 | $1 |
| Total debt | $3.3 | $3.73 | $3.19 | $1 |
| Total liabilities | $7.16 | $6.25 | $6.03 | $2.14 |
| Shareholders' equity | ||||
| Retained earnings | -$51.13 | -$42.04 | -$29.36 | -$11.29 |
| Other shareholder equity | -$0.17 | -$0.19 | -$0.26 | -$0.24 |
| Total shareholder equity | $3.08 | $4.12 | $4.47 | $12.12 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.29 | $0.3 | $0.33 | $0.49 |
| Cost of revenue | $0.21 | $0.22 | $0.24 | $0.32 |
| Gross Profit | $0.08 | $0.08 | $0.1 | $0.17 |
| Operating activities | ||||
| Research & development | $0.25 | $0.12 | $0.35 | $0.22 |
| Selling, general & administrative | $0.88 | $1.27 | $1.03 | $0.69 |
| Total operating expenses | $2.92 | $2.21 | $2.36 | $2.13 |
| Operating income | -$2.84 | -$2.13 | -$2.26 | -$1.96 |
| Income from continuing operations | ||||
| EBIT | -$1.93 | -$2.03 | -$2.28 | -$1.97 |
| Income tax expense | ||||
| Interest expense | $0.09 | $0.04 | $0.06 | $0.05 |
| Net income | ||||
| Net income | -$2.03 | -$2.07 | -$2.33 | -$2.02 |
| Income (for common shares) | -$2.03 | -$2.07 | -$2.33 | -$2.02 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.39 | $1.38 | $1.55 | $1.56 |
| Cost of revenue | $0.98 | $0.99 | $1.21 | $1.17 |
| Gross Profit | $0.41 | $0.39 | $0.34 | $0.39 |
| Operating activities | ||||
| Research & development | $1.03 | $0.88 | $1.78 | |
| Selling, general & administrative | $3.28 | $5.41 | $16.93 | $4.54 |
| Total operating expenses | $9.25 | $12.84 | $19.72 | $8.02 |
| Operating income | -$8.83 | -$12.45 | -$19.38 | -$7.63 |
| Income from continuing operations | ||||
| EBIT | -$8.89 | -$12.51 | -$17.46 | -$7.46 |
| Income tax expense | ||||
| Interest expense | $0.2 | $0.17 | $0.61 | $0.31 |
| Net income | ||||
| Net income | -$9.09 | -$12.68 | -$18.07 | -$7.77 |
| Income (for common shares) | -$9.09 | -$12.68 | -$18.07 | -$7.77 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | -$2.03 | -$2.07 | -$2.33 | -$2.02 |
| Operating activities | ||||
| Depreciation | $0.12 | $0.12 | $0.12 | $0.12 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.22 | $0.61 | $0.49 | $0.53 |
| Total cash flows from operations | -$2.18 | -$0.51 | -$1.72 | -$0.71 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0 | -$0.02 | |
| Investments | -$0.05 | -$0 | ||
| Total cash flows from investing | -$0.05 | -$0 | -$0 | -$0.02 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.14 | $0.34 | $0.04 | |
| Net borrowings | $2.92 | $0.1 | $1.79 | $0.57 |
| Total cash flows from financing | $2.9 | $0.23 | $1.99 | $0.58 |
| Effect of exchange rate | -$0.02 | $0 | $0 | $0 |
| Change in cash and equivalents | $0.65 | -$0.28 | $0.28 | -$0.15 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$9.09 | -$12.68 | -$18.07 | -$7.77 |
| Operating activities | ||||
| Depreciation | $0.44 | $0.38 | $0.51 | $0.52 |
| Business acquisitions & disposals | -$0.35 | |||
| Stock-based compensation | $2.11 | $5.49 | $9.21 | $3.09 |
| Total cash flows from operations | -$5.02 | -$7.55 | -$7.08 | -$4.4 |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.11 | -$0.39 | -$0.5 |
| Investments | -$0.04 | -$0.06 | -$0.45 | |
| Total cash flows from investing | -$0.07 | -$0.17 | -$0.55 | -$1.31 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.86 | $7.03 | ||
| Net borrowings | $2.55 | $8.2 | $8.46 | -$0.5 |
| Total cash flows from financing | $5.17 | $7.66 | $6.15 | $5.04 |
| Effect of exchange rate | $0 | $0.01 | -$0.01 | -$0.11 |
| Change in cash and equivalents | $0.08 | -$0.04 | -$1.49 | -$0.77 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 89.03M |
| Revenue | $1.41M |
|---|---|
| EBITDA | -$7.74M |
| EBIT | -$8.21M |
| Net Income | -$8.46M |
| Revenue Q/Q | 3.78% |
| Revenue Y/Y | 4.44% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 0.00 |
| Cash/Share | 0.01 |
| EPS | -$0.09 |
|---|---|
| ROA | -83.37% |
| ROE | -529.18% |
| Debt/Equity | 2.32 |
|---|---|
| Net debt/EBITDA | -1.15 |
| Current ratio | 0.23 |
| Quick ratio | 0.23 |